Back
Raia Drogasil SA Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
47
RADLY
Raia Drogasil SA
Last Price:
5.00
Seasonality Move:
12.46%
Sell
14
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
1.9%
Sell
47
Raia Drogasil SA (RADLY)
is a Sell
Is Raia Drogasil SA a Buy, Sell or Hold?
- The current Raia Drogasil SA [RADLY] share price is $5.00. The Score for RADLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RADLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RADLY Stock Price Chart
What is Raia Drogasil SA's stock price today?
-
The Raia Drogasil SA share price today is $5.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RADLY is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
RADLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 44.04 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.84 - 5.5) | Sell |
Bollinger Bands (100): | (5.08 - 6.7) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 38.85 | Sell |
Chaikin Money Flow: | -1654308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.07 - 0.09) | Buy |
Bollinger Bands (100): | (0.1 - 0.18) | Sell |
RADLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5 | Sell |
20-day SMA: | 5.12 | Sell |
50-day SMA: | 5.38 | Sell |
200-day SMA: | 5.68 | Sell |
8-day EMA: | 5.02 | Sell |
20-day EMA: | 5.11 | Sell |
50-day EMA: | 5.35 | Sell |
200-day EMA: | 5.64 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Sell |
20-day SMA: | 0.08 | Sell |
50-day SMA: | 0.11 | Sell |
200-day SMA: | 0.3 | Sell |
8-day EMA: | 0.09 | Sell |
20-day EMA: | 0.09 | Sell |
50-day EMA: | 0.11 | Sell |
200-day EMA: | 0.52 | Sell |
Raia Drogasil SA Earnings Growth & RADLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Raia Drogasil SA Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |